Rachel Leung

When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

‘Unapproved medicines’, ‘compassionate use’, ‘early access drugs’..

In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.

A groundbreaking year helping patients access the latest approved medicines.

Is there substance to the claims that it's a groundbreaking treatment?

Why can it take us three to four weeks to deliver a medicine, and what can customers do to speed things up?

Introducing a breakthrough known as 'CT1812'

How effective is alectinib (Alecensa)? The latest news and updates

 We live in an age where you can hop online to order a new brand of lipstick if it hasn’t been released yet in your country. 

An insight into the team, and how we constantly review our progress at TheSocialMedwork